Byetta Lawsuit Information Center
If you or a loved one were prescribed an incretin mimetic used to treat adults with type-2 diabetes, start the process of filing a Byetta lawsuit against the manufacturer. The attorneys at Bernstein Liebhard LLP are actively monitoring the string of recent reports and alerts from the U.S. Food and Drug Administration (FDA) that have highlighted Byetta’s link to pancreatitis, pancreatic cancer and possibly thyroid cancer. Call a Byetta lawyer for a free and confidential case evaluation today.
The first Byetta lawsuit alleging injuries caused by the diabetes drug was filed in 2008, a year after the FDA issued its first side effect alert involving the medication. Claims involving this medication seek compensation for lost wages, medical expenses, pain and suffering and other damages caused by the patient’s alleged injuries.
Byetta Lawsuit Allegations
Over the past few years, the FDA has investigated the link between Byetta and pancreatitis, pancreatic cancer, thyroid cancer and renal (kidney) failure as more patients have come forward to file reports noting these injuries. Plaintiffs in Byetta lawsuits allege these diseases may lead to frequent and expensive hospitalization, lost wages and pain and suffering. If this sounds like you, contact Bernstein Liebhard LLP today.
Byetta pancreatic cancer side effects:
The following symptoms may be signs of Byetta pancreatic cancer:
- Back pain
- Weight loss
- Pale colored stools
- Abdominal pain
- Enlarged lymph nodes.
Symptoms of Byetta pancreatitis:
- Abdominal pain and tenderness
- Abdominal pain radiating into the back
- Increased heart rate
- Swelling of the abdomen
In addition to these diseases, Byetta has also been suggested to cause renal (kidney failure), which may lead to death if left un-treated. If you are experiencing nausea, decreased urine output, sweating, anorexia, confusion, swelling in the feet and legs, it is imperative that you call your doctor today. Immediate intervention and possibly surgery may be necessary to treat your condition.
In November 2009, the FDA alerted the public that at least 78 reports of altered kidney function had been filed with the agency, along with 62 reports of Byetta kidney failure. That month, the FDA announced that these reports would be added to new prescribing information about kidney failure and other kidney problems.
This health warning was issued four years after the makers of Byetta, Amylin Pharmaceuticals, Inc. received FDA approval for the medication on April 28th, 2005. According to the manufacturer, “BYETTA was the first FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of patients with type 2 diabetes. BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
Byetta is a self-injected type-2 diabetes drug administered prior to meals. The medication, which belongs to a class of medications known as incretin mimetics, has been tied to pancreatitis, pancreatic cancer and thyroid cancer, among other complications. Numerous Byetta side effect warnings have been issued by the FDA since 2007, and may affect Byetta lawsuits.
FDA Notifications May Affect Your Byetta Lawsuit
In one such Byetta warning announced on August 8, 2008, the FDA released the following statement: “Since issuing Information for Healthcare Professionals in October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Of the 6 cases of hemorrhagic or necrotizing pancreatitis, all patients required hospitalization, two patients died and four patients were recovering at time of reporting.”
Although Amylin has not confirmed that the FDA has asked them to change the labeling for Byetta, the following warning has been listed on the company’s website:
“Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. After initiation of BYETTA, and after dose increases, observe patients carefully for signs and symptoms of pancreatitis (including persistent severe abdominal pain, sometimes radiating to the back, which may or may not be accompanied by vomiting). If pancreatitis is suspected, BYETTA should promptly be discontinued and appropriate management should be initiated. If pancreatitis is confirmed, BYETTA should not be restarted. Consider anti-diabetic therapies other than BYETTA in patients with a history of pancreatitis.”
How Much Do Byetta Lawsuits Cost?
There is certain information vital to anyone pursuing a Byetta lawsuit. For one, each state in the U.S. has specific statute of limitations (SOL) that govern the amount of time an individual has to file a case. Federal and state regulations may also play a role and FDA notifications may affect time limitations, in some instances.
It is also important to remember that your initial consultation in speaking with a Byetta lawyer is free, which you may arrange for by calling our toll-free number. By working with a lawyer at Bernstein Liebhard LLP, you can rest easy knowing you will receive the one-on-one attention your case deserves.
Symptoms you may experience after taking Byetta may vary depending on the illness you develop. In order to protect your health and legal rights, it is vital to keep track of all medical records, times absent from work and lost wages you may have experienced as a result of your alleged injuries. This information will serve as important evidence in your Byetta lawsuit.
Contact Bernstein Liebhard LLP to File a Byetta Lawsuit
If you or a loved one was damaged by Byetta, or you developed an illness because of the diabetes drug, it is vital that you protect your health and legal rights by seeking the aid of a Byetta lawyer. Filing a claim against Amylin may earn you financial compensation caused by your injuries. Fill out a contact form below or give us a call today at to speak with an attorney at Bernstein Liebhard LLP who will evaluate your case for free.